New effort on collaboration over product serialization
Globaltrackandtrace.org will try to build industry consensus on pharma security, traceability
There is enough industry attention being paid to product serialization and pedigree, apparently, that a new group can form up to try to move the technology forward. The group is called globaltrackandtrace.org, and is being founded by Excellis Consulting (Devon, PA) and Axway (Scottsdale, AZ). A first-time “Leadership Forum” will be held on Nov. 5 in Newton Square, PA.
“Past efforts to move this technology forward have suffered because the players involved—manufacturers, distributors, retailers and government—often were focused on their own agenda,” says Greg Cathcart, president of Excellis (and a former executive at SupplyScape, the now-defunct pioneering company that developed some of the original drug-pedigree methodology). “By bringing trading partners together in an open forum, we hope to get them talking about common goals.”
“Our expectation is that this will be more about deriving business value from serialization, and less about meeting a regulatory deadline,” says Sia Zadeh, director of business development at Axway. He also emphasizes that serialization needs to be looked at in a global context; in fact, serialization activity is more active now in Europe than in the US.
The GS1 organization, coordinator of product identification technology standards, and AMR Research, a market research company, will also be involved in the initial meeting.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
